Neuroprotective effects of microRNA-210 against oxygen-glucose deprivation through inhibition of apoptosis in PC12 cells

Molecular Medicine Reports

Volumn 7, Issue 6, 2013, Pages 1955-1959

  Qiu, Jie ^a   Zhou, Xiao Yu ^a   Zhou, Xiao Guang ^a   Cheng, Rui ^a   Liu, Hai Ying ^a   Li, Yong ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Gene therapy; Hypoxic ischemic encephalopathy; MicroRNA 210

Indexed keywords

CASPASE; MICRORNA 210; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EX VIVO STUDY; GENE EXPRESSION REGULATION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; PC12 CELL; PROTEIN SYNTHESIS REGULATION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; GLUCOSE; HYPOXIA-ISCHEMIA, BRAIN; MICRORNAS; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; OXYGEN; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TRANSFECTION; UP-REGULATION;

EID: 84877285234     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1431     Document Type: Article

References (51)

1. du Plessis AJ and Volpe JJ: Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 15: 151-157, 2002.
2. Gonzalez FF and Ferriero DM: Therapeutics for neonatal brain injury. Pharmacol Ther 120: 43-53, 2008.
3. Shankaran S and Laptook AR: Hypothermia as a treatment for birth asphyxia. Clin Obstet Gynecol 50: 624-635, 2007.
4. Whitelaw A and Thoresen M: Clinical trials of treatments after perinatal asphyxia. Curr Opin Pediatr 14: 664-668, 2002.
5. Lawn JE, Cousens S and Zupan J; Lancet Neonatal Survival Steering Team: 4 million neonatal deaths: when? Where? Why? Lancet 365: 891-900, 2005.
6. Fotopoulos S, Pavlou K, Skouteli H, Papassotiriou I, Lipsou N and Xanthou M: Early markers of brain damage in premature low-birth-weight neonates who suffered from perinatal asphyxia and/or infection. Biol Neonate 79: 213-218, 2001.
7. Allin M, Matsumoto H, Santhouse AM, et al: Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain 124: 60-66, 2001.
8. Isaacs EB, Edmonds CJ, Chong WK, Lucas A, Morley R and Gadian DG: Brain morphometry and IQ measurements in preterm children. Brain 127: 2595-2607, 2004.
9. Casiro OG, Moddemann DM, Stanwick RS, Panikkar-Thiessen VK, Cowan H and Cheang MS: Language development of very low birth weight infants and fullterm controls at 12 months of age. Early Hum Dev 24: 65-77, 1990.
10. Marlow N, Rose AS, Rands CE and Draper ES: Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 90: F380-F387, 2005.
11. Steinman KJ, Gorno-Tempini ML, Glidden DV, et al: Neonatal watershed brain injury on magnetic resonance imaging correlates with verbal IQ at 4 years. Pediatrics 123: 1025-1030, 2009.
12. Tioseco JA, Aly H, Essers J, Patel K and El-Mohandes AA: Male sex and intraventricular hemorrhage. Pediatr Crit Care Med 7: 40-44, 2006.
13. Bacon AL and Harris AL: Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann Med 36: 530-539, 2004.
14. Gordan JD and Simon MC: Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17: 71-77, 2007.
15. Gruber M and Simon MC: Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr Opin Hematol 13: 169-174, 2006.
16. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
17. Kim JW, Tchernyshyov I, Semenza GL and Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185, 2006.
18. Koumenis C: ER stress, hypoxia tolerance and tumor progression. Curr Mol Med 6: 55-69, 2006.
19. Pocock R: Invited review: decoding the microRNA response to hypoxia. Pflugers Arch 461: 307-315, 2011.
20. Ivan M, Harris AL, Martelli F and Kulshreshtha R: Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12: 1426-1431, 2008.
21. Chan SY and Loscalzo J: MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9: 1072-1083, 2010.
22. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL and Loscalzo J: MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10: 273-284, 2009.
23. Chen Z, Li Y, Zhang H, Huang P and Luthra R: Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29: 4362-4368, 2010.
24. Favaro E, Ramachandran A, McCormick R, et al: MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 5: e10345, 2010.
25. Huang X, Ding L, Bennewith KL, et al: Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867, 2009.
26. Kushibiki T: Photodynamic therapy induces microRNA-210 and -296 expression in HeLa cells. J Biophotonics 3: 368-372, 2010.
27. Pulkkinen K, Malm T, Turunen M, Koistinaho J and Ylä-Herttuala S: Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 582: 2397-2401, 2008.
28. Camps C, Buffa FM, Colella S, et al: hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348, 2008.
29. Jeyaseelan K, Lim KY and Armugam A: MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39: 959-966, 2008.
30. Liu DZ, Tian Y, Ander BP, et al: Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 30: 92-101, 2010.
31. Fasanaro P, D'Alessandra Y, Di Stefano V, et al: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008.
32. Tabakman R, Lazarovici P and Kohen R: Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 68: 463-469, 2002.
33. Guo G and Bhat NR: p38alpha MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline's neuroprotective action. Neurochem Res 32: 2160-2166, 2007.
34. Tabakman R, Jiang H, Schaefer E, Levine RA and Lazarovici P: Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 Model. J Mol Neurosci 22: 237-250, 2004.
35. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144, 2006.
36. Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4: 199-227, 2009.
37. Kim J, Krichevsky A, Grad Y, et al: Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci USA 101: 360-365, 2004.
38. Kosik KS and Krichevsky AM: The Elegance of the MicroRNAs: A Neuronal Perspective. Neuron 47: 779-782, 2005.
39. Schratt GM, Tuebing F, Nigh EA, et al: A brain-specific microRNA regulates dendritic spine development. Nature 439: 283-289, 2006.
40. Kulshreshtha R, Ferracin M, Wojcik SE, et al: A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867, 2007.
41. Giannakakis A, Sandaltzopoulos R, Greshock J, et al: miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7: 255-264, 2008.
42. Crosby ME, Kulshreshtha R, Ivan M and Glazer PM: MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69: 1221-1229, 2009.
43. Hu S, Huang M, Li Z, et al: MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122: S124-S131, 2010.
44. Bittigau P, Sifringer M, Genz K, et al: Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 99: 15089-15094, 2002.
45. Ikonomidou C, Bosch F, Miksa M, et al: Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74, 1999.
46. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23: 876-882, 2003.
47. Sanders RD, Ma D, Brooks P and Maze M: Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicity. Br J Anaesth 101: 597-609, 2008.
48. Pardridge WM: Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opin Biol Ther 4: 1103-1113, 2004.
49. Pardridge WM: shRNA and siRNA delivery to the brain. Adv Drug Deliv Rev 59: 141-152, 2007.
50. Kuida K, Haydar TF, Kuan CY, et al: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325-337, 1998.
51. Kuida K, Zheng TS, Na S, et al: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372, 1996.